Zynex, Inc.’s NASDAQ Uplisting

Sichenzia Ross Ference represented Zynex, Inc. (NASDAQ: ZYXI), in the Company’s uplisting to the NASDAQ Capital Market

Zynex, Inc. (OTCQB: ZYXI) common shares have been approved to list on The Nasdaq Capital Market and is expected to begin trading under its existing symbol (ZYXI) on February 12, 2019.

Zynex, Inc. is an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics

The Sichenzia Ross Ference LLP team was led by Gregory Sichenzia (Picture) and Tara Guarneri-Ferrara.

Involved fees earner: Tara Guarneri-Ferrara – Sichenzia Ross Ference LLP; Gregory Sichenzia – Sichenzia Ross Ference LLP;

Law Firms: Sichenzia Ross Ference LLP;

Clients: Zynex, Inc.;

Author: Ambrogio Visconti